<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2384">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00927108</url>
  </required_header>
  <id_info>
    <org_study_id>RH-CMR-005</org_study_id>
    <nct_id>NCT00927108</nct_id>
  </id_info>
  <brief_title>Rajavtihi Neuronal Adult Stem Cells Project</brief_title>
  <acronym>RNASc</acronym>
  <official_title>Adult Neuronal Progenitor Stem Cell Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rajavithi Biomolecular Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the success of Oligodendrocyte progenitor cell culture project in Rajavithi Hospital&#xD;
      to identify an unlimited clone human neuronal progenitor stem cells from the human brain in&#xD;
      the Biomolecular Research Center. This study aims to produce the reproductive clone of&#xD;
      neuronal development protocols and advance projects. Neuronal cells such as pyramidal cells,&#xD;
      oligodendrocyte, and dopaminergic neuron differentiation protocol/projects for treatment of&#xD;
      Alzheimer's disease, Multiple sclerosis, and Parkinson's disease respectively in next phase&#xD;
      of clinical trials.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date type="Actual">July 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Cell culture</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment type="Actual">0</enrollment>
  <condition>Alzheimer's Disease</condition>
  <condition>Parkinson's Disease</condition>
  <condition>Multiple Sclerosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Progenitor Stem Cell Culture</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have elective craniotomy or.&#xD;
&#xD;
          -  Patients who have elective ventriculostomy surgery or.&#xD;
&#xD;
          -  Patients who have elective muscle biopsy or nerve biopsy.&#xD;
&#xD;
          -  Patient who have emergency craniectomy for life threatening from emergency medical and&#xD;
             surgical conditions such as Brain herniation or head injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Central nervous system infection for example tuberculous or any bacterial infection,&#xD;
             Viral infection, fungal infection.&#xD;
&#xD;
          -  Central nervous system Tumor, Malignancy and metastasis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Subsai Kongsaengdao, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rajavithi Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rajavithi Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10140</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>June 22, 2009</study_first_submitted>
  <study_first_submitted_qc>June 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2009</study_first_posted>
  <last_update_submitted>October 14, 2020</last_update_submitted>
  <last_update_submitted_qc>October 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adult Progenitor Stem cells</keyword>
  <keyword>Alzheimer's disease</keyword>
  <keyword>Parkinson's disease</keyword>
  <keyword>Multiple sclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

